Deutsche Bank Ag\ Genetic Technologies LTD Transaction History

Deutsche Bank Ag\

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 04, 2021	SELL	$0.0 - $0.01 $0 - $150	-15,071 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.0 - $0.0 $0 - $0	15,071 New	15,071 $34,000
Q1 2020 May 14, 2020	SELL	$0.0 - $0.0 $0 - $0	-1,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.0 - $0.0 $0 - $0	1,000 New	1,000 $1,000

Ticker GENE
Exchange OTC
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 15,389,900
Market Cap $11.9M
Description
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to ...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.